119 related articles for article (PubMed ID: 21713359)
21. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
Chandrasekher G; Sailaja D
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3577-88. PubMed ID: 15452065
[TBL] [Abstract][Full Text] [Related]
22. Human breast carcinoma cells are induced to apoptosis by samsum ant venom through an IGF-1-dependant pathway, PI3K/AKT and ERK signaling.
Badr G; Garraud O; Daghestani M; Al-Khalifa MS; Richard Y
Cell Immunol; 2012; 273(1):10-6. PubMed ID: 22218396
[TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
Friedrichs N; Küchler J; Endl E; Koch A; Czerwitzki J; Wurst P; Metzger D; Schulte JH; Holst MI; Heukamp LC; Larsson O; Tanaka S; Kawai A; Wardelmann E; Buettner R; Pietsch T; Hartmann W
J Pathol; 2008 Dec; 216(4):428-39. PubMed ID: 18855347
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor receptor I targeting in epithelial ovarian cancer.
Gotlieb WH; Bruchim I; Gu J; Shi Y; Camirand A; Blouin MJ; Zhao Y; Pollak MN
Gynecol Oncol; 2006 Feb; 100(2):389-96. PubMed ID: 16300820
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.
Law JH; Habibi G; Hu K; Masoudi H; Wang MY; Stratford AL; Park E; Gee JM; Finlay P; Jones HE; Nicholson RI; Carboni J; Gottardis M; Pollak M; Dunn SE
Cancer Res; 2008 Dec; 68(24):10238-46. PubMed ID: 19074892
[TBL] [Abstract][Full Text] [Related]
26. Substrate-bound insulin-like growth factor (IGF)-I-IGF binding protein-vitronectin-stimulated breast cell migration is enhanced by coactivation of the phosphatidylinositide 3-Kinase/AKT pathway by alphav-integrins and the IGF-I receptor.
Hollier BG; Kricker JA; Van Lonkhuyzen DR; Leavesley DI; Upton Z
Endocrinology; 2008 Mar; 149(3):1075-90. PubMed ID: 18079201
[TBL] [Abstract][Full Text] [Related]
27. PKCη is a negative regulator of AKT inhibiting the IGF-I induced proliferation.
Shahaf G; Rotem-Dai N; Koifman G; Raveh-Amit H; Frost SA; Livneh E
Exp Cell Res; 2012 Apr; 318(7):789-99. PubMed ID: 22305966
[TBL] [Abstract][Full Text] [Related]
28. Sensitivity of breast cancer cell lines to the novel insulin-like growth factor-1 receptor (IGF-1R) inhibitor NVP-AEW541 is dependent on the level of IRS-1 expression.
Mukohara T; Shimada H; Ogasawara N; Wanikawa R; Shimomura M; Nakatsura T; Ishii G; Park JO; Jänne PA; Saijo N; Minami H
Cancer Lett; 2009 Sep; 282(1):14-24. PubMed ID: 19345478
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor.
Knowlden JM; Hutcheson IR; Barrow D; Gee JM; Nicholson RI
Endocrinology; 2005 Nov; 146(11):4609-18. PubMed ID: 16037379
[TBL] [Abstract][Full Text] [Related]
30. Cell lineage-specific signaling of insulin and insulin-like growth factor I in rabbit blastocysts.
Navarrete Santos A; Ramin N; Tonack S; Fischer B
Endocrinology; 2008 Feb; 149(2):515-24. PubMed ID: 17962341
[TBL] [Abstract][Full Text] [Related]
31. trans-10,cis-12 conjugated linoleic acid inhibits insulin-like growth factor-I receptor signaling in TSU-Pr1 human bladder cancer cells.
Jung JI; Cho HJ; Kim J; Kwon DY; Park JH
J Med Food; 2010 Feb; 13(1):13-9. PubMed ID: 20136431
[TBL] [Abstract][Full Text] [Related]
32. Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathway.
Luey BC; May FE
Mol Cancer; 2016 Jan; 15():8. PubMed ID: 26801096
[TBL] [Abstract][Full Text] [Related]
33. Nimbolide inhibits IGF-I-mediated PI3K/Akt and MAPK signalling in human breast cancer cell lines (MCF-7 and MDA-MB-231).
Elumalai P; Arunkumar R; Benson CS; Sharmila G; Arunakaran J
Cell Biochem Funct; 2014 Jul; 32(5):476-84. PubMed ID: 24888707
[TBL] [Abstract][Full Text] [Related]
34. Effects of insulin, insulin-like growth factor-I and -II on proliferation and intracellular signaling in endometrial carcinoma cells with different expression levels of insulin receptor isoform A.
Wang CF; Zhang G; Zhao LJ; Li XP; Qi WJ; Wang JL; Wei LH
Chin Med J (Engl); 2013; 126(8):1560-6. PubMed ID: 23595395
[TBL] [Abstract][Full Text] [Related]
35. Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system.
Chimento A; Sirianni R; Zolea F; De Luca A; Lanzino M; Catalano S; Andò S; Pezzi V
J Cell Physiol; 2012 May; 227(5):2079-88. PubMed ID: 21769864
[TBL] [Abstract][Full Text] [Related]
36. Luteolin decreases IGF-II production and downregulates insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells.
Lim DY; Cho HJ; Kim J; Nho CW; Lee KW; Park JH
BMC Gastroenterol; 2012 Jan; 12():9. PubMed ID: 22269172
[TBL] [Abstract][Full Text] [Related]
37. Functional role of alpha-actinin, PI 3-kinase and MEK1/2 in insulin-like growth factor I receptor kinase regulated motility of human breast carcinoma cells.
Guvakova MA; Adams JC; Boettiger D
J Cell Sci; 2002 Nov; 115(Pt 21):4149-65. PubMed ID: 12356918
[TBL] [Abstract][Full Text] [Related]
38. FUS-DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid Liposarcoma.
Trautmann M; Menzel J; Bertling C; Cyra M; Isfort I; Steinestel K; Elges S; Grünewald I; Altvater B; Rossig C; Fröhling S; Hafner S; Simmet T; Åman P; Wardelmann E; Huss S; Hartmann W
Clin Cancer Res; 2017 Oct; 23(20):6227-6238. PubMed ID: 28637688
[No Abstract] [Full Text] [Related]
39. Picropodophyllin inhibits type I endometrial cancer cell proliferation via disruption of the PI3K/Akt pathway.
Dong L; Du M; Lv Q
Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):753-760. PubMed ID: 31168597
[TBL] [Abstract][Full Text] [Related]
40. Oral glutamine (AES-14) supplementation inhibits PI-3k/Akt signaling in experimental breast cancer.
Todorova VK; Harms SA; Luo S; Kaufmann Y; Babb KB; Klimberg VS
JPEN J Parenter Enteral Nutr; 2003; 27(6):404-10. PubMed ID: 14621121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
